Literature DB >> 5116226

Structure and tumor-promoting activity of anthralin (1,8-dihydroxy-9-anthrone) and related compounds.

A Segal, C Katz, B L Van Duuren.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5116226     DOI： 10.1021/jm00294a002

Source DB:  PubMed          Journal:  J Med Chem        ISSN： 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  6 in total

Review 1.  Psoriasis. A review of recent advances in treatment.

Authors:  E M Farber; L Nall
Journal:  Drugs       Date:  1984-10       Impact factor: 9.546

2.  Characteristics and modulation of dithranol (anthralin)-induced skin irritation in the mouse ear model.

Authors:  M Viluksela
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

3.  Toxicological studies with dithranol and its 10-acyl analogues.

Authors:  P T Männistö; D Kirkland; M Viluksela; L Tikkanen
Journal:  Arch Toxicol       Date:  1986-10       Impact factor: 5.153

4.  The antipsoriatic drug, anthralin, inhibits protein kinase C--implications for its mechanism of action.

Authors:  L Hegemann; R Fruchtmann; L A van Rooijen; R Müller-Peddinghaus; G Mahrle
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

5.  Cocarcinogenic and tumor-promoting capabilities of anthralin.

Authors:  N Z Baturay; L D Trombetta
Journal:  Arch Dermatol Res       Date:  1988       Impact factor: 3.017

6.  Induction of intestinal tumours in rats by chrysazin.

Authors:  H Mori; S Sugie; K Niwa; M Takahashi; K Kawai
Journal:  Br J Cancer       Date:  1985-11       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.